News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,020 Results
Type
Article (42177)
Company Profile (713)
Press Release (688115)
Multimedia
Podcasts (127)
Webinars (28)
Section
Business (206115)
Career Advice (2394)
Deals (37947)
Drug Delivery (151)
Drug Development (81335)
Employer Resources (173)
FDA (16414)
Job Trends (15624)
News (349316)
Policy (31610)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2178)
Academic (1)
Accelerated approval (50)
Adcomms (30)
Allergies (176)
Alliances (49678)
ALS (218)
Alzheimer's disease (1840)
Antibody-drug conjugate (ADC) (506)
Approvals (16780)
Artificial intelligence (761)
Autoimmune disease (335)
Automation (55)
Bankruptcy (381)
Best Places to Work (11581)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (438)
Bladder cancer (190)
Brain cancer (77)
Breast cancer (756)
Cancer (5987)
Cardiovascular disease (507)
Career advice (2030)
Career pathing (49)
CAR-T (347)
CDC (45)
Celiac Disease (3)
Cell therapy (975)
Cervical cancer (49)
Clinical research (70925)
Collaboration (2230)
Company closure (7)
Compensation (1424)
Complete response letters (98)
COVID-19 (2659)
CRISPR (114)
C-suite (1224)
Cystic fibrosis (158)
Data (8145)
Decentralized trials (3)
Denatured (23)
Depression (174)
Dermatology (86)
Diabetes (599)
Diagnostics (7245)
Digital health (59)
Diversity (7)
Diversity, equity & inclusion (42)
Drug discovery (367)
Drug pricing (217)
Drug shortages (30)
Duchenne muscular dystrophy (297)
Earnings (90548)
Editorial (72)
Employer branding (24)
Employer resources (154)
Events (123603)
Executive appointments (1148)
FDA (20227)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1815)
Gene editing (255)
Generative AI (72)
Gene therapy (772)
GLP-1 (1144)
Government (4007)
Grass and pollen (8)
Guidances (408)
Healthcare (18020)
HIV (87)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (103)
Immunology and inflammation (318)
Immuno-oncology (105)
Indications (192)
Infectious disease (3013)
Inflammatory bowel disease (229)
Inflation Reduction Act (13)
Influenza (143)
Intellectual property (302)
Interviews (456)
IPO (17501)
IRA (53)
Job creations (4392)
Job search strategy (1655)
JPM (63)
Kidney cancer (18)
Labor market (99)
Layoffs (657)
Leadership (47)
Legal (7780)
Liver cancer (100)
Longevity (31)
Lung cancer (794)
Lymphoma (423)
Machine learning (64)
Management (61)
Manufacturing (1131)
MASH (209)
Medical device (14596)
Medtech (14733)
Mergers & acquisitions (21733)
Metabolic disorders (1603)
mRNA (231)
Multiple sclerosis (194)
NASH (19)
Neurodegenerative disease (457)
Neuropsychiatric disorders (118)
Neuroscience (3453)
Neurotech (1)
NextGen: Class of 2026 (6581)
Non-profit (3584)
Now hiring (80)
Obesity (760)
Opinion (345)
Ovarian cancer (220)
Pain (261)
Pancreatic cancer (320)
Parkinson's disease (391)
Partnered (35)
Patents (617)
Patient recruitment (718)
Peanut (64)
People (62186)
Pharmaceutical (125)
Pharmacy benefit managers (31)
Phase 1 (22197)
Phase 2 (31473)
Phase 3 (23424)
Pipeline (9122)
Policy (334)
Postmarket research (2245)
Preclinical (9294)
Press Release (68)
Prostate cancer (316)
Psychedelics (63)
Radiopharmaceuticals (352)
Rare diseases (1154)
Real estate (6164)
Recruiting (73)
Regulatory (25349)
Reports (48)
Research institute (2221)
Resumes & cover letters (370)
Rett syndrome (40)
RNA editing (24)
RSV (89)
Schizophrenia (187)
Series A (313)
Series B (229)
Service/supplier (25)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (170)
Sponsored (46)
Startups (4023)
State (2)
Stomach cancer (18)
Supply chain (133)
Tariffs (99)
The Weekly (102)
Vaccines (1151)
Venture capital (122)
Weight loss (507)
Women's health (119)
Worklife (24)
Date
Today (219)
Last 7 days (618)
Last 30 days (3613)
Last 365 days (31706)
2026 (14038)
2025 (31801)
2024 (36793)
2023 (41415)
2022 (52252)
2021 (56132)
2020 (53856)
2019 (45691)
2018 (34931)
2017 (34131)
2016 (33122)
2015 (38771)
2014 (31374)
2013 (26159)
2012 (27787)
2011 (28134)
2010 (25841)
Location
Africa (824)
Alabama (100)
Alaska (7)
Arizona (299)
Arkansas (15)
Asia (44340)
Australia (7328)
California (13776)
Canada (3844)
China (1461)
Colorado (579)
Connecticut (602)
Delaware (407)
Europe (98783)
Florida (2010)
Georgia (442)
Hawaii (4)
Idaho (64)
Illinois (1034)
India (99)
Indiana (640)
Iowa (25)
Japan (554)
Kansas (131)
Kentucky (52)
Louisiana (42)
Maine (85)
Maryland (1542)
Massachusetts (10118)
Michigan (388)
Minnesota (759)
Mississippi (5)
Missouri (155)
Montana (35)
Nebraska (28)
Nevada (150)
New Hampshire (88)
New Jersey (3622)
New Mexico (32)
New York (3606)
North Carolina (1839)
North Dakota (10)
Northern California (6912)
Ohio (408)
Oklahoma (23)
Oregon (52)
Pennsylvania (2713)
Puerto Rico (30)
Rhode Island (51)
South America (1201)
South Carolina (85)
South Dakota (1)
Southern California (5353)
Tennessee (213)
Texas (2164)
United States (48642)
Utah (407)
Vermont (1)
Virginia (339)
Washington D.C. (83)
Washington State (1133)
West Virginia (4)
Wisconsin (145)
Wyoming (2)
731,020 Results for "cole parmer instrument company acquired by fisher scientific international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Cole-Parmer Is Back in Peristaltic Pumps
Cole-Parmer, an Antylia Scientific company, is pleased to reintroduce peristaltic pumps to enhance its industry-leading line of fluid handling solutions.
June 13, 2024
·
2 min read
Press Releases
Thermo Fisher Scientific’s PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden
May 18, 2026
·
3 min read
Press Releases
Thermo Fisher Scientific Reports First Quarter 2026 Results
April 23, 2026
·
18 min read
Press Releases
Thermo Fisher Scientific Announces Quarterly Dividend - May 20, 2026
May 21, 2026
·
1 min read
Press Releases
Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM
March 31, 2026
·
3 min read
BioMidwest
Cole-Parmer Re-launches Fluid Handling Product Line
Cole-Parmer, an Antylia Scientific company, is launching an all-new range of industry-leading fluid handling solutions initially comprised of tubing, fittings, parts, and accessories to suit a diverse array of research and production needs.
April 8, 2024
·
1 min read
Press Releases
Thermo Fisher Scientific to Host Investor Day - April 28, 2026
April 28, 2026
·
1 min read
Press Releases
Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity
April 17, 2026
·
4 min read
Press Releases
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
April 27, 2026
·
6 min read
Press Releases
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.
March 24, 2026
·
7 min read
1 of 73,102
Next
